Important Dates

ACMT Pre-Symposium
Wed. September 17

ACMT 26th Annual Clinical Pathological (CPC) Presentation Competition
Thu. September 18

ACMT FIT Roundtable | The Medical Toxicologist as a Medical-Legal Expert
Fri. September 19

ACMT Practice Symposium |
The Great THC Debate
Sat. September 20

ACMT Scientific Symposium |
The Toxicology of Sleep
Sat. September 20

ACMT FIT Visiting Professor Lecture | Who? Me? UME: Medical Toxicologists in Undergraduate Medical Education
Sun. September 21

ACMT Activities at #NACCT2025

Join ACMT at the 2025 North American Congress of Clinical Toxicology (NACCT) in Chicago from September 17-21, 2025.

In addition to the ACMT Pre-Meeting, Beyond the Beat: Toxicology and Harm Reduction at Mass Gatherings on Wednesday, September 17th, ACMT will participate in a number of other activities and programming throughout #NACCT2025.

Main Conference Activities

Thursday, September 18 • 5:00 PM – 7:00 PM
ACMT 26th Annual Clinical Pathological (CPC) Presentation Competition

  • Jeffrey Suchard, MD, Professor of Clinical Emergency Medicine & Associate Dean for Basic Science Education, University of California, Irvine (Moderator)

Description
Now in its 26th year, ACMT’s Clinical Pathological Case (CPC) Competition is a highlight of NACCT, where selected mentor/mentee teams present and solve complex, real-world toxicology cases in front of a live audience. Each discussant is challenged to walk through a clinical differential diagnosis without knowing the final outcome in advance. Submissions are welcome from across specialties—including Emergency Medicine, Pediatrics, Occupational Medicine, and Pharmacy—as long as the senior team member is an ACMT Member with an academic supervisory role. This fast-paced session blends clinical reasoning, toxicologic expertise, and educational insight into an engaging and suspenseful competition.


Friday, Sept. 19 • 4:30 PM – 5:30 PM
ACMT FIT Roundtable | The Medical Toxicologist as a Medical-Legal Expert

  • Jeffrey Brent, MD, PhD, FACMT, Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care) and Emergency Medicine University of Colorado School of Medicine and Public Health (Moderator)
  • Benjamin Hatten, MD, MPH, Medical Toxicologist, Toxicology Associates & Associate Professor of Emergency Medicine, University of Colorado
  • Jerrold B. Leikin, MD, FACP, FACEP, FACMT, FAACT, FACOEM, FASAM, Adjunct Clinical Professor Division of Environmental and Occupational Health Sciences & Professor of Medicine, University of Illinois Chicago and Rosalind Franklin University of Medicine & Science

Description & Learning Objectives – coming soon!


Saturday, Sept. 20 • 10:30 – 11:30 AM
ACMT Practice Symposium | The Great THC Debate: Emerging Cannabinoids, Controversies, and Evolving Regulations

  • Joseph Kennedy, MD, Emergency Medicine Physician, University of Vermont Medical Center (Moderator)
  • Marit Tweet, MD, Emergency Medicine Physician, Southern Illinois University
  • Antonia Nemanich, MD, Assistant Professor, Rush University Medical Center
  • Carol Deslauriers, PharmD, Illinois Poison Center (Debate Judge)
  • Leslie Mendoza Temple, MD, ABOIM, Owen L. Coon Foundation Chair of Integrative Medicine, NorthShore Endeavor Health (Debater)
  • Jerrold B. Leikin, MD, FACP, FACEP, FACMT, FAACT, FACOEM, FASAM, Adjunct Clinical Professor Division of Environmental and Occupational Health Sciences & Professor of Medicine, University of Illinois Chicago and Rosalind Franklin University of Medicine & Science (Debater)

Description
As the cannabis landscape rapidly evolves, clinicians and toxicologists face mounting challenges in addressing the rise of novel psychoactive cannabinoids and shifting regulatory frameworks. This dynamic session will begin with updates on emerging compounds like delta-8 THC, delta-10 THC, and THC-O acetate, exploring their pharmacology, legal status, and toxicological significance. The second half will feature a lively structured debate on the therapeutic value and public health impact of THC legalization. Attendees will gain a deeper understanding of the clinical, regulatory, and societal implications of cannabis and its derivatives.

Learning Objectives
1. Recognize the growing prevalence of alternative psychoactive cannabinoids, their pharmacology, and the evolving legal landscape that governs their distribution and use.
2. Evaluate the therapeutic and toxicological consequences of cannabis legalization, including government and industry interventions that have shaped patient outcomes over the past decade.
3. Engage in a structured debate on the risks and benefits of THC use, gaining insights from differing perspectives on its impact on public health and clinical practice.


Saturday, Sept. 20 • 1:00 PM – 2:00 PM
ACMT Scientific Symposium | The Toxicology of Sleep

  • Erin Hanlon, PhD, Research Associate Professor of Medicine, Department of Medicine, Section of Endocrinology, Diabetes, and Metabolism, University of Chicago
  • Stephanie Weiss, MD PhD MS, Staff Research Physician and Assistant Director for Clinical Research, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health (Moderator)

Description
Marking the 100th anniversary of the world’s first sleep research laboratory—founded by Nathaniel Kleitman at the University of Chicago—this session explores the intersection of sleep and toxicology. Presentations from both preclinical and clinical perspectives will examine how xenobiotics influence sleep induction, architecture, and quality, with discussion of agents such as cannabinoids, alcohol, sedatives, stimulants, and pharmaceuticals. Attendees will also consider the role of medications in sleep regulation and the emerging understanding of the metabolic consequences of insufficient sleep.

Learning Objectives
1. Explain the molecular mechanisms and pharmacology contributing to sleep and review the clinical phases of sleep.
2. Explore the relationships between xenobiotics and sleep induction, architecture, and quality.


Sunday, Sept. 21 • 9:00 AM – 10:00 AM
FIT Visiting Professor Lecture | Who? Me? UME: Medical Toxicologists in Undergraduate Medical Education

  • Jeffrey Suchard, MD, Professor of Clinical Emergency Medicine & Associate Dean for Basic Science Education, University of California, Irvine
  • Trevonne Thompson, MD, FACEP, FACMT, Associate Dean of Admissions, College of Medicine, University of Illinois at Chicago
  • Saralyn Williams, MD, FACMT, FACEP, Vice Chair of Faculty Affairs, Vanderbilt Emergency Medicine
  • Matthew Zuckerman, MD, Associate Professor, Emergency Medicine-Medical Toxicology and Pharmacology, University of Colorado School of Medicine and Public Health
  • Andrew King, MD, Associate Professor in the Department of Emergency Medicine & Medical Director, Wayne State University School of Medicine & Michigan Poison and Drug Information Center (Moderator)

Description
Undergraduate medical education (UME) presents an exciting array of opportunities for medical toxicologists. As medical schools shift toward integrated curricula—where foundational science is taught in a clinical context—clinical toxicologists are uniquely positioned to contribute. This session explores how medical toxicologists can expand beyond guest lecturing to curriculum development, clerkship direction, and leadership roles within medical education.

Learning Objectives
1. Identify teaching opportunities for medical toxicologists within undergraduate medical education (UME).
2. Discuss the current framework of UME and opportunities to engage with and support that framework.
3. Outline multiple potential career paths for medical toxicologists within UME, including instructional, curricular development, and administrative roles.